ArticleLupus science & medicine2026

Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data.

Angela Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.